Moolec Science (NASDAQ:MLEC) Stock Rating Upgraded by Wall Street Zen

Moolec Science (NASDAQ:MLEC) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday.

Moolec Science Stock Performance

NASDAQ MLEC opened at $7.27 on Friday. The stock has a market capitalization of $5.31 million, a P/E ratio of -0.22 and a beta of -0.36. Moolec Science has a 1 year low of $3.08 and a 1 year high of $157.05. The business’s fifty day moving average is $9.40 and its two-hundred day moving average is $8.13.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC purchased a new stake in Moolec Science SA (NASDAQ:MLEC) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 0.07% of the company’s stock.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.